Dawn Kalmar
Chief Communications Officer
Stoke Therapeutics
Bio:
Dawn Kalmar is one of the most influential corporate affairs leaders in biotech. In her 25-year career Dawn has played a leading role in delivering multiple first-in-class medicines at premiere biotechnology companies, including Genentech and Vertex. Her strategic mindset, integrated approach to communications and deep experience have made her a key contributor to the C-suite. Dawn currently serves as Chief Communications Officer for Stoke Therapeutics where she is responsible for corporate communications, investor relations, government affairs and patient advocacy. Dawn has seen the company through its IPO and helped the company advance its lead investigational new medicine into late-stage development.